397O Avelumab plus cetuximab in pre-treated RAS wild type metastatic colorectal cancer patients as a rechallenge strategy: The phase II CAVE (cetuximab-avelumab) mCRC study
Authors:
- E. MartinelliEME. Martinelli
- G. MartiniGMG. Martini
- T. TroianiTTT. Troiani
- F. PietrantonioFPF. Pietrantonio
- A. AvalloneAAA. Avallone
- N. NormannoNNN. Normanno
- A. NappiANA. Nappi
- E. MaielloEME. Maiello
- A. FalconeAFA. Falcone
- G. SantabarbaraGSG. Santabarbara
- C. PintoCPC. Pinto
- D. SantiniDSD. Santini
- 1 September 2020
- journal article
- abstracts
- Published by Elsevier in Annals of Oncology
- Vol. 31, S409-S410